PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers.
Today, many immunoassay... - May 17, 2018 - Mercodia AB
Virun® NutraBIOsciences® and Algarithm™ Ingredients Announce O3Omega™ Smoothies Line Picked Up by Canadian Retail Giant Co-op so People Can Enjoy Plant-Based Omega 3s Every Day, the Easy Way, Notice of Allowance for Patent Covering Spray-Dried Powders Containing Non-Polar Compounds. - May 10, 2018 - VIRUN
Apostle Inc is pleased to announce it’s been accepted into the prestigious StartX accelerator program. StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The acceptance rate has been between 8%-10%. - May 05, 2018 - Apostle Inc
Arteric's President Shares How AI Detects Important Signals of Audience Behavior - May 04, 2018 - Arteric
LayerBio will present preclinical study results at the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii on Monday, April 30. These results demonstrate the therapeutic potential of its novel extended-release travoprost formulation using LayerBio's proprietary PolyNet™ delivery technology. - April 27, 2018 - LayerBio, Inc.
The new website offers visitors rich insights into the Company’s lead stem cell product, StemPlan, and applied expertise of the therapeutic and biotechnology applications of stem cells. The website also provides a complete overview of the Company’s GMP facilities and service offerings engineered to harness the power of stem cells and regenerative medicine. - April 18, 2018 - BioDivide Limited
Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more than... - April 18, 2018 - Cayman Chemical Company
Arteric's President and Chief Strategist Shares Case Studies and Insights. - April 16, 2018 - Arteric
Two food safety and management systems consulting and training powerhouses are teaming up to take you to the next level. The professional partnership between D.L. Newslow & Associates and Savour Food Safety International brings an exciting and dynamic new angle to the industry, with a fresh face of service to manufacturing companies across the U.S. and beyond. - April 11, 2018 - D.L. Newslow & Associates, Inc.
Security, Productivity, and Industrial Control Modules included in latest version.
Tornado Spectral Systems Inc., a leading manufacturer of Raman spectrometers, released today an enhanced update of its flagship software SpectralSoft. Version 2.8 equips users with essential functionality including security... - April 11, 2018 - Tornado Spectral Systems
AdvantaPure has been issued a second U.S. patent for its AdvantaPass technology. The system maintains the separation of room atmospheres to minimize contamination risks in biopharm and pharmaceutical processing. Improvements that warranted the second patent include welded wall portals, the elimination of adhesives and sealants and adjustable wall flanges. The upgrades offer users more options regarding mounting and using the system. - April 06, 2018 - AdvantaPure
Vidan Diagnostics Expected to Provide Access to Unique Tests Related to Monitoring of Diabetes and Sepis. - April 05, 2018 - Vidan Diagnostics, LLC
Apostle Inc is pleased to announce the launch of a joint venture with Southern University of Science and Technology (SUSTech) in Shenzhen, China. The joint venture, Apostle-SUSTech Inc, will focus on the scientific and business activities in the Greater China region. David Ge, President of Apostle Inc;... - April 04, 2018 - Apostle Inc
Dr. Sanjay Razdan, a Urologist from the International Robotic Prostatectomy Institute in Miami, Florida was just recognized as one of the Best Urologists in Florida in 2018 by Three Best Rated. Dr. Razdan has also been nominated for the prestigious Healthcare Heroes award by the Greater Miami Chamber of Commerce.
- April 03, 2018 - International Robotic Prostatectomy Institute
Proteos, Inc. has been recognized as one of the 2018 “Best Small Businesses,” an awards program presented by Michigan Celebrates Small Business.
Proteos will receive the SmartZone Best Small Business of the Year Award and be honored at an awards ceremony during the fourteenth annual Michigan... - March 24, 2018 - Proteos
PuRxCell Offers Physicians Stem Cell Training, Protocols and Products.
Robert J. Colucci CEO of PuRxCell, LLC, a Florida based company, announced today that PuRxCell, has named Dr. Jeimylo C. de Castro as its Medical Director for the Philippine Islands and parts of Asia.
“Doctor de Castro is... - March 23, 2018 - PuRxCell
The Choosing Wisely® in North Carolina initiative – which aims to reduce health care waste by helping patients make smart and effective health care choices – has resulted in significant reductions in the unnecessary use of antibiotics, Pap tests and scans for osteoporosis. - March 23, 2018 - NCHQA
Arteric's President Shares Case Studies and Essentials for Success - March 22, 2018 - Arteric
PharmaLink is the New Partner in Drug Returns Processing
Value Drug, a top-rated wholesaler to independent pharmacies, announced another industry leading initiative with PharmaLink. Together they will now provide to all of their members a full array of services in the take back and processing of expired... - March 14, 2018 - PharmaLink
Aciont Inc. announced today that Dr. Kongnara Papangkorn, VP of Product Development, will be presenting clinical data of Aciont’s lead product, DSP-Visulex, from its phase 1/2 clinical trial in the treatment of noninfectious anterior uveitis (DSPV-201) at the Association for Research in Vision... - March 10, 2018 - Aciont Inc.
ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director.
“I have a passion for medical care and the difference it makes in the lives... - March 10, 2018 - Wake Research Associates
Virun® NutraBIOsciences® Showcases Hot Young Musical Talent, Hosts Informative Panel Discussions and Presents its’ New Product Offering to the Masses at Inaugural Music and Food Science Event. - March 01, 2018 - VIRUN
Leader Biomedical is pleased to announce the phased acquisition of International Orthopaedics Holding GmbH (International Orthopaedics), a manufacturer and distributor of orthopaedic implants based in Geisingen, Germany. The companies have entered into a notarial deed on the 20th of February, 2018. This... - March 01, 2018 - Leader Biomedical
Experimentica Ltd. has been selected for Phase 1 of the Young Innovative Company program by Business Finland (formerly known as TEKES, The Finnish Funding Agency for Technology and Innovation). The funding awarded for the first phase is a 250,000 € grant for a period of 12 months.
“Every... - February 21, 2018 - Experimentica Ltd
Apostle Inc is pleased to announce the appointment of Alexander J. Hartemink, PhD as a new member to its Scientific Advisory Board. Dr. Hartemink is Professor of Computer Science and Biology at Duke University. He is the faculty director of the Office of Undergraduate Scholars and Fellows and the active... - February 19, 2018 - Apostle Inc
Latest patent covers an endoscopic-based cryocatheter (FrostBite™) designed to provide an advanced approach for targeting pancreatic and other gastroenterological based cancers. - February 15, 2018 - CPSI Biotech
MD Stem Cells publishing positive, statistically significant results on treatments in SCOTS. - February 13, 2018 - MD Stem Cells
Study Director for multiple stem cell studies continues contributions to international scientific community. - February 13, 2018 - MD Stem Cells
MD Stem Cells coordinates latest technologies to advance stem cell treatment of paraplegia. - February 12, 2018 - MD Stem Cells
Apostle Inc is pleased to announce the appointment of David B. Goldstein, PhD as a new member to its Scientific Advisory Board. Dr. Goldstein is John E. Borne Professor of Medical and Surgical Research at Columbia University. - February 11, 2018 - Apostle Inc
With highly qualified sales and support staff covering both Canada and the United States and extensive expertise in supplying the life sciences with novel and high quality scientific instrumentation, Scintica is perfectly placed to partner with Oxford Optronix.
The Scintica team consists of scientists,... - February 07, 2018 - Scintica Instrumentation
Proteos, Inc. announced on Monday January 29, 2018 that the company would begin the process of restructuring and transitioning to a majority employee-owned corporation. Since its founding in 2003, by Clark W. Smith, Ph.D. and Robert L. Heinrikson, Ph.D., Proteos has been committed to both customer and... - February 03, 2018 - Proteos
Many people are looking at their parents, grandparents and families and seeing cancer, diabetes, heart disease and rare diseases, all of which can have a genetic component. South Asians have twice the rate of genetic disease compared to the rest of the world, yet there is far less data, less than 1% of the available data. So people don’t know what they are carrying, and they want better diagnosis and treatments for their family members. #MaptheGap will start to address this. - February 02, 2018 - Map the Gap
Phelix Therapeutics, LLC is pleased to announce it has received a $201,665 grant from the National Institutes of Health (NIH). This Small Business Innovation Research (SBIR) funding will support Phelix’s continued research of Calpain therapeutics to inhibit myofibroblast generation in fibrosis... - January 31, 2018 - Phelix Therapeutics, LLC
Visitors will also receive a free consultation at the body composition analyzer’s booth (#409) in the Henry B. Gonzalez Convention Center in San Antonio, TX. - January 31, 2018 - InBody
NanoHybrids, announces the launch of PAtrace, a proprietary nanoparticle that provides high resolution visualization and verification of the enhanced permeability and retention (EPR) effect in heterogeneous tumor models. PAtrace is being launched at the 2018 SPIE BioS Expo. - January 29, 2018 - NanoHybrids
Eagle Biosciences, Inc. is proud to announce the launch of a new assay, MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit. MedFrontier FGF23 (Human Intact FGF23) ELISA Assay Kit utilizes a simple 96 well sandwich ELISA procedure that measures ONLY the full-length active form (intact form) in under three hours. - January 26, 2018 - Eagle Biosciences, Inc.
Wake Research Welcomes Christine Heironimus as New Director of Business Development and Strategic Network Acceleration. - January 25, 2018 - Wake Research Associates
Attendees will also receive a free consultation at InBody’s booth (#200) in Caesar’s Palace from January 23rd to January 24th. - January 24, 2018 - InBody
Arteric.com named Best Advertising Mobile Website and Best Interactive Services Mobile Website. - January 17, 2018 - Arteric
The European Commission has adopted the following on 8 January 2018: Adoption of Commission Implementing Decision granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council for "Intrarosa - Prasterone," a medicinal product for human use. - January 15, 2018 - Endoceutics
As DrugCendR is now preparing to transition from a preclinical to a
clinical-stage company, the company will present details on their Phase I–ready lead compound CEND-1 – a highly innovative molecular mimicry agent that is able to activate a drug transport mechanism specifically in solid tumors. To date, there are more than 100 studies using DrugCendR’s proprietary technology, providing an unprecedented amount of preclinical validation / proof-of-concept. - January 04, 2018 - DrugCendR
SARI is a Chinese market-leader biotech investment company. - December 30, 2017 - NMS Group
NuvOx Pharma, a clinical stage biotechnology company, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke (NINDS). This grant will fund development of a novel syringe sonication device that may... - December 30, 2017 - NuvOx Pharma
Stem Cell Ophthalmology Treatment Study in Florida makes progress treating “untreatable” optic nerve and retinal conditions with publication of positive outcomes. - December 29, 2017 - MD Stem Cells
Single-Use filling assemblies for fill and finish applications in biopharmaceutical and pharmaceutical processing are now available from AdvantaPure. They feature molded connections for seamless fluid flow. Supplied sterilized and ready to install, the assemblies are manufactured with tubing, bags, filters, sterile connectors, filling needles and other accessories specified by the customer. Two tubing materials are offered. - December 21, 2017 - AdvantaPure
Siva Therapeutics in partnership with NanoHybrids have teamed to develop and manufacture gold nanoparticles for treating cancer with hyperthermia. The nanoparticle treatment was submitted to the Frederick National Laboratory for Cancer Research and has passed the first stages in the Nanotechnology Characterization Laboratory, which helps pave the way for regulatory review of nanotechnologies intended for cancer therapies and diagnostics. - December 15, 2017 - NanoHybrids
NanoHybrids Inc. has been awarded $300,000 by the National Cancer Institute of the National Institutes of Health (NIH) through the Small Business Technology Transfer (STTR) program to enhance the therapeutic efficacy of photodynamic therapy (PDT) in oral cancers. - December 15, 2017 - NanoHybrids
BioStat Solutions, Inc. today announced that Eloi Kpamegan, Ph.D. has accepted the position of Director, Clinical Operations. - December 14, 2017 - BioStat Solutions, Inc.
A presentation at the Southwestern Association of Toxicologists November 2017 scientific meeting in San Antonio, Texas highlighted the utility of Cayman’s Synthetic Cannabinoid Screening Library. This library is comprised of more than 350 synthetic cannabinoid standards, including parent compounds... - December 14, 2017 - Cayman Chemical Company